HK Stock Market Move | Trump threatens to impose tariffs on pharmaceuticals, causing a widespread drop in healthcare stocks. HBM HOLDINGS-B (02142) fell more than 7%.

In the early morning trading session, pharmaceutical stocks generally fell, as of the time of writing, HBM HOLDINGS-B (02142) fell by 7.06% to HK$8.04; JUNSHI BIO (01877) fell by 6.38% to HK$14.98; REMEGEN (09995) fell by 6.48% to HK$38.25; WuXi AppTec (02359) fell by 3.61% to HK$60.1; Asymchem Laboratories (06821) fell by 3.74% to HK$55.35. In terms of news, according to reports, Trump told reporters at the White House that he will announce significant news regarding drug costs next week, "because we have been taken advantage of." He believes that drug costs in the U.S. are overestimated compared to other countries in the world. The order requires the FDA to streamline review processes, and to provide early support to domestic manufacturers before facilities go online. Trump also said on Monday local time that he will announce tariffs on drugs within the next two weeks. Sinolink's recent research report pointed out that the pharmaceutical sector has experienced a significant pullback due to changes in the international tariff environment and geopolitical expectations. However, the firm believes that the pharmaceutical sector has good risk resistance and growth capabilities, and the innovative drug sector has low geopolitical and tariff risks, making it a growth mainstay in the pharmaceutical sector. They continue to be bullish on the growth potential of Hong Kong and A-share innovative drug targets.